These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 35612120)
21. Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions. Li R; Curtis K; Zaidi STR; Van C; Thomson A; Castelino R Expert Opin Drug Saf; 2021 Oct; 20(10):1267-1274. PubMed ID: 34077311 [No Abstract] [Full Text] [Related]
22. [Adverse drug reaction reports in Iceland from 2013 to 2016. A comparison with other Nordic countries]. Jonsdottir SS; Olafsdottir SM; Gudmundsdottir H Laeknabladid; 2017 Jul; 103(07-08):319-323. PubMed ID: 28816174 [TBL] [Abstract][Full Text] [Related]
23. Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients. Giraud EL; Jessurun NT; van Hunsel FPAM; van Puijenbroek EP; van Tubergen A; Ten Klooster PM; Vonkeman HE Expert Opin Drug Saf; 2020 Dec; 19(12):1617-1624. PubMed ID: 32990050 [TBL] [Abstract][Full Text] [Related]
24. Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011. Aagaard L; Hansen EH Int J Clin Pharm; 2014 Dec; 36(6):1222-9. PubMed ID: 25288145 [TBL] [Abstract][Full Text] [Related]
25. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543 [TBL] [Abstract][Full Text] [Related]
26. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register. Wallerstedt SM; Brunlöf G; Sundström A Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827 [TBL] [Abstract][Full Text] [Related]
27. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases. Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439 [TBL] [Abstract][Full Text] [Related]
28. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study. Johansson ML; Hägg S; Wallerstedt SM BMC Clin Pharmacol; 2011 Sep; 11():14. PubMed ID: 21899766 [TBL] [Abstract][Full Text] [Related]
29. Characteristics of pediatric adverse drug reaction reports in the Japanese Adverse Drug Event Report Database. Noda A; Sakai T; Obara T; Miyazaki M; Tsuchiya M; Oyanagi G; Murai Y; Mano N BMC Pharmacol Toxicol; 2020 May; 21(1):36. PubMed ID: 32448369 [TBL] [Abstract][Full Text] [Related]
30. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database. Castillon G; Salvo F; Moride Y Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742 [TBL] [Abstract][Full Text] [Related]
31. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study. Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498 [TBL] [Abstract][Full Text] [Related]
32. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis. Zhou Z; Hultgren KE JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889 [TBL] [Abstract][Full Text] [Related]
33. Paradoxical adverse drug reactions: descriptive analysis of French reports. Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024 [TBL] [Abstract][Full Text] [Related]
34. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented. Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001 [TBL] [Abstract][Full Text] [Related]
35. Hepatic adverse drug reactions in Malaysia: An 18-year review of the national centralized reporting system. Lee FY; Wong HS; Chan HK; Mohamed Ali N; Abu Hassan MR; Omar H; Abdul Mutalib NA Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1669-1679. PubMed ID: 33064335 [TBL] [Abstract][Full Text] [Related]
36. Experiences with adverse drug reaction reporting by patients: an 11-country survey. van Hunsel F; Härmark L; Pal S; Olsson S; van Grootheest K Drug Saf; 2012 Jan; 35(1):45-60. PubMed ID: 22149419 [TBL] [Abstract][Full Text] [Related]
37. Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre. Jonville-Béra AP; Saissi H; Bensouda-Grimaldi L; Beau-Salinas F; Cissoko H; Giraudeau B; Autret-Leca E Drug Saf; 2009; 32(5):429-40. PubMed ID: 19419237 [TBL] [Abstract][Full Text] [Related]
38. Factors affecting patient reporting of adverse drug reactions: a systematic review. Al Dweik R; Stacey D; Kohen D; Yaya S Br J Clin Pharmacol; 2017 Apr; 83(4):875-883. PubMed ID: 27868226 [TBL] [Abstract][Full Text] [Related]
39. Analysis of Immunogenicity Data in the Product Information of Biological Drugs: A Need to Report Immunogenicity Data Systematically. Borrega R; Cruz JP; Taylor P; Goncalves J BioDrugs; 2019 Dec; 33(6):683-691. PubMed ID: 31595484 [TBL] [Abstract][Full Text] [Related]
40. Data-driven prediction of adverse drug reactions induced by drug-drug interactions. Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]